Essential cross-linking role for FcgRIIB in the in vivo activity of anti-CD40 monoclonal antibody

被引：0
|
作者：
White, A. L. [1 ]
Chan, H. T. C. [1 ]
French, R. R. [1 ]
Roghanian, A. [1 ]
Mockridge, C. I. [1 ]
Tutt, A. L. [1 ]
Verbeek, J. S. [2 ]
Noelle, R. J. [3 ]
Al-Shamkhani, A. [1 ]
Cragg, M. S. [1 ]
Beers, S. A. [1 ]
Glennie, M. J. [1 ]
机构：
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Kings Coll London, MRC, Ctr Transplantat, London WC2R 2LS, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [1] Anti-CD40 monoclonal antibody
    Geldart, T
    Illidge, T
    LEUKEMIA & LYMPHOMA, 2005, 46 (08) : 1105 - 1113
  • [2] In Vivo Characterization of a Novel Recombinant Anti-CD40 Monoclonal Antibody in Nonhuman Primates
    Badell, I. R.
    Mendel, J. B.
    Robertson, J. M.
    Johnson, B. E.
    Wang, X.
    Wang, R.
    Iwakoshi, N. N.
    Reimann, K. A.
    Kirk, A. D.
    Larsen, Christian P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 214 - 214
  • [3] Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40
    Law, CL
    Gordon, KA
    Collier, J
    Klussman, K
    McEarchern, JA
    Cerveny, CG
    Mixan, BJ
    Lee, WP
    Lin, ZH
    Valdez, P
    Wahl, AF
    Grewal, IS
    CANCER RESEARCH, 2005, 65 (18) : 8331 - 8338
  • [4] Preclinical antitumor activity of a humanized anti-CD40 monoclonal antibody SGN-40.
    Law, CL
    Lee, WP
    Lin, ZH
    Grewal, IS
    Wahl, A
    BLOOD, 2003, 102 (11) : 646A - 646A
  • [5] Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody
    Kim, KM
    Min, HY
    Jung, SH
    Lee, TH
    Kim, JG
    Kang, CY
    HYBRIDOMA, 1998, 17 (05): : 463 - 470
  • [6] Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
    White, Ann L.
    Chan, H. T. Claude
    Roghanian, Ali
    French, Ruth R.
    Mockridge, C. Ian
    Tutt, Alison L.
    Dixon, Sandra V.
    Ajona, Daniel
    Verbeek, J. Sjef
    Al-Shamkhani, Aymen
    Cragg, Mark S.
    Beers, Stephen A.
    Glennie, Martin J.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (04): : 1754 - 1763
  • [7] Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14
    Francisco, JA
    Donaldson, KL
    Chace, D
    Siegall, CB
    Wahl, AF
    CANCER RESEARCH, 2000, 60 (12) : 3225 - 3231
  • [8] Anti-CD40 monoclonal antibody ameliorates experimental autoimmune uveoretinitis in mice
    Xu, Lei
    Gao, Jie
    Pan, Yongquan
    Tian, Na
    He, Mingzhong
    Jin, Lei
    Chen, Feilan
    VETERINARY OPHTHALMOLOGY, 2020, 23 (05) : 797 - 805
  • [9] ANTI-CD40 MONOCLONAL ANTIBODIES DO NOT INDUCE THROMBOEMBOLISM IN VITRO OR IN VIVO
    Rubic-Schneider, Tina
    Christen, Brigitte
    Flandre, Thierry
    de Billy, Benjamin Cochin
    Cote, Serge
    Nock, Sebastian
    Runser-Loll, Nathalie
    Garcia, Deborah
    Erard, Esther
    Ulrich, Peter
    Rush, James
    TRANSPLANT INTERNATIONAL, 2019, 32 : 205 - 205
  • [10] Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells
    Qi, CH
    Zheng, L
    Zhou, X
    Tao, Y
    Ge, Y
    Zhuang, YM
    Xu, Y
    Yu, GH
    Zhang, XG
    IMMUNOLOGY LETTERS, 2004, 93 (2-3) : 151 - 158
12345